Indofarma Tbk (INAF) - Total Liabilities

Latest as of September 2025: Rp1.47 Trillion IDR ≈ $86.28 Million USD

Based on the latest financial reports, Indofarma Tbk (INAF) has total liabilities worth Rp1.47 Trillion IDR (≈ $86.28 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Indofarma Tbk to track the company's year-over-year net asset growth rate.

Indofarma Tbk - Total Liabilities Trend (2000–2024)

This chart illustrates how Indofarma Tbk's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Indofarma Tbk to measure how efficiently the company converts operating cash flow to free cash.

Indofarma Tbk Competitors by Total Liabilities

The table below lists competitors of Indofarma Tbk ranked by their total liabilities.

Company	Country	Total Liabilities
Pudjiadi & Sons Tbk JK:PNSE	Indonesia	Rp155.87 Billion
Master Pack Group Bhd KLSE:7029	Malaysia	RM22.17 Million
Andromeda Metals Ltd AU:ADN	Australia	AU$2.27 Million
Pulsenmore Ltd TA:PULS	Israel	ILA45.83 Million
Transtema Group AB ST:TRANS	Sweden	Skr1.00 Billion
Mistral Iberia Real Estate SOCIMI S.A. MC:YMIB	Spain	€11.51 Million
Heavy Minerals Ltd AU:HVY	Australia	AU$3.53 Million
Gryphon Digital Mining Inc. NASDAQ:GRYP	USA	$17.19 Million

Liability Composition Analysis (2000–2024)

This chart breaks down Indofarma Tbk's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see INAF market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.13	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.65	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	2.53	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Indofarma Tbk's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Indofarma Tbk (2000–2024)

The table below shows the annual total liabilities of Indofarma Tbk from 2000 to 2024.

Year	Total Liabilities	Change
2024-12-31	Rp1.76 Trillion ≈ $103.26 Million	+12.67%
2023-12-31	Rp1.56 Trillion ≈ $91.64 Million	+8.04%
2022-12-31	Rp1.45 Trillion ≈ $84.83 Million	-3.72%
2021-12-31	Rp1.50 Trillion ≈ $88.10 Million	+17.19%
2020-12-31	Rp1.28 Trillion ≈ $75.18 Million	+45.96%
2019-12-31	Rp879.00 Billion ≈ $51.51 Million	-7.05%
2018-12-31	Rp945.70 Billion ≈ $55.41 Million	-5.76%
2017-12-31	Rp1.00 Trillion ≈ $58.80 Million	+24.52%
2016-12-31	Rp805.88 Billion ≈ $47.22 Million	-14.36%
2015-12-31	Rp941.00 Billion ≈ $55.14 Million	+43.36%
2014-12-31	Rp656.38 Billion ≈ $38.46 Million	-6.73%
2013-12-31	Rp703.72 Billion ≈ $41.24 Million	+30.68%
2012-12-31	Rp538.52 Billion ≈ $31.55 Million	+6.49%
2011-12-31	Rp505.71 Billion ≈ $29.63 Million	+19.64%
2010-12-31	Rp422.69 Billion ≈ $24.77 Million	-1.54%
2009-12-31	Rp429.31 Billion ≈ $25.16 Million	-35.85%
2008-12-31	Rp669.22 Billion ≈ $39.21 Million	-6.78%
2007-12-31	Rp717.87 Billion ≈ $42.06 Million	+76.62%
2006-12-31	Rp406.45 Billion ≈ $23.82 Million	+60.29%
2005-12-31	Rp253.58 Billion ≈ $14.86 Million	-5.47%
2004-12-31	Rp268.26 Billion ≈ $15.72 Million	-27.11%
2003-12-31	Rp368.02 Billion ≈ $21.56 Million	-10.68%
2002-12-31	Rp412.04 Billion ≈ $24.14 Million	+40.06%
2001-12-31	Rp294.19 Billion ≈ $17.24 Million	+19.78%
2000-12-31	Rp245.61 Billion ≈ $14.39 Million	--

About Indofarma Tbk

JK:INAF Indonesia Drug Manufacturers - Specialty & Generic

Market Cap

$22.88 Million

Rp390.51 Billion IDR

Market Cap Rank

#24617 Global

#518 in Indonesia

Share Price

Rp126.00

Change (1 day)

+0.00%

52-Week Range

Rp126.00 - Rp126.00

All Time High

Rp6975.00